Page last updated: 2024-09-02

asulacrine and Bone Marrow Diseases

asulacrine has been researched along with Bone Marrow Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baguley, BC; Carmichael, J; Fyfe, D; Gardner, C; Houghton, J; Langley, RE; Osborne, L; Pagonis, C; Price, C; Woll, PJ	1

Trials

1 trial(s) available for asulacrine and Bone Marrow Diseases

Article	Year
A phase I trial of amsalog (CI-921) administered by intravenous infusion using a 5-day schedule. Cancer chemotherapy and pharmacology, 2001, Volume: 47, Issue:4 Topics: Adult; Aged; Amsacrine; Antineoplastic Agents; Area Under Curve; Bone Marrow Diseases; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Half-Life; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Topoisomerase II Inhibitors	2001

Article

Year

A phase I trial of amsalog (CI-921) administered by intravenous infusion using a 5-day schedule.

Cancer chemotherapy and pharmacology, 2001, Volume: 47, Issue:4

Topics: Adult; Aged; Amsacrine; Antineoplastic Agents; Area Under Curve; Bone Marrow Diseases; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Half-Life; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Topoisomerase II Inhibitors

2001